18.17

1.14% -0.25

Theravance Biopharma Inc (TBPH)

Overview News Price History Option Chain Financials Discussions Forecast

Theravance Biopharma Inc stock is traded at $18.17, with a volume of 376.69K. It is down -1.14% in the last 24 hours and down -1.83% over the past month. Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Previous Close:

$18.42

Open:

$18.34

24h Volume:

376.69K

Relative Volume:

0.84

Market Cap:

$920.21M

Revenue:

$62.02M

Net Income/Loss:

$-45.65M

P/E Ratio:

-19.75

EPS:

-0.92

Net Cash Flow:

$-9.60M

1W Performance:

-3.70%

1M Performance:

-1.83%

6M Performance:

+63.32%

1Y Performance:

+98.15%

1-Day Range:

$18.05

$18.69

1-Week Range:

$17.59

$19.21

52-Week Range:

$7.90

$20.33

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name

Theravance Biopharma Inc

Sector

Healthcare (1126)

Industry

Biotechnology (624)

Phone

650-808-6000

Address

UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

TBPH's Discussions on Twitter

Compare TBPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TBPH Theravance Biopharma Inc	18.16	933.39M	62.02M	-45.65M	-9.60M	-0.92
VRTX Vertex Pharmaceuticals Inc	468.00	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	775.08	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	405.94	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.86	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	174.84	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-25	Initiated	Oppenheimer	Outperform
Sep-12-25	Initiated	B. Riley Securities	Buy
Aug-06-24	Downgrade	Leerink Partners	Outperform → Market Perform
Apr-12-24	Initiated	BTIG Research	Buy
Jan-08-24	Downgrade	Evercore ISI	Outperform → In-line
May-23-22	Initiated	SVB Leerink	Outperform
Nov-05-21	Upgrade	JP Morgan	Underweight → Neutral
Sep-15-21	Downgrade	JP Morgan	Overweight → Underweight
Aug-25-21	Downgrade	Morgan Stanley	Overweight → Underweight
Aug-24-21	Downgrade	Cowen	Outperform → Market Perform
Oct-14-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jul-07-20	Initiated	JP Morgan	Overweight
Jun-15-20	Initiated	Morgan Stanley	Equal-Weight
May-13-20	Initiated	Cowen	Outperform
Jan-08-20	Reiterated	H.C. Wainwright	Buy
Nov-06-19	Upgrade	Robert W. Baird	Underperform → Neutral
Oct-29-19	Initiated	H.C. Wainwright	Buy
Mar-29-18	Resumed	Piper Jaffray	Overweight
Aug-17-17	Initiated	Evercore ISI	Outperform
Jun-16-17	Initiated	Cantor Fitzgerald	Overweight
May-11-17	Reiterated	Needham	Buy
Dec-21-16	Initiated	Needham	Buy
Nov-03-16	Initiated	Piper Jaffray	Overweight
Oct-12-16	Downgrade	Robert W. Baird	Neutral → Underperform
Aug-03-16	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-20-16	Initiated	Guggenheim	Buy
Jun-20-16	Reiterated	Leerink Partners	Outperform
May-12-16	Initiated	Leerink Partners	Outperform
May-05-16	Downgrade	BofA/Merrill	Buy → Neutral
Feb-03-15	Upgrade	Robert W. Baird	Underperform → Neutral

View All

Theravance Biopharma Inc Stock (TBPH) Latest News

Jan 05, 2026

mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jan 05, 2026

Jan 03, 2026

Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat

Jan 03, 2026

(TBPH) Volatility Zones as Tactical Triggers - Stock Traders Daily

Jan 03, 2026

Theravance Biopharma (NASDAQ:TBPH) Lowered to Buy Rating by Wall Street Zen - MarketBeat

Jan 03, 2026

Jan 02, 2026

Portfolio Update: Why Theravance Biopharma Inc 0TB stock stays resilient2025 Short Interest & Daily Entry Point Alerts - moha.gov.vn

Jan 02, 2026

Can Theravance Biopharma's Ampreloxetine Fill The Gap In MSA-Related NOH Therapy? - RTTNews

Jan 02, 2026

Jan 01, 2026

Market Overview: Is Theravance Biopharma Inc stock trading near support levels2025 Macro Impact & Weekly Return Optimization Plans - moha.gov.vn

Jan 01, 2026

Dec 28, 2025

What drives Theravance Biopharma Inc stock priceMarket Insider Reports & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in

Dec 28, 2025

Dec 26, 2025

Inspire Investing LLC Purchases New Position in Theravance Biopharma, Inc. $TBPH - MarketBeat

Dec 26, 2025

Dec 24, 2025

Here's Why Theravance Biopharma (TBPH) is a Strong Growth Stock - sharewise.com

Dec 24, 2025

Dec 23, 2025

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Dec 23, 2025

Dec 22, 2025

Wall Street Analysts Believe Theravance Bio (TBPH) Could Rally 42.15%: Here's is How to Trade - Finviz

Dec 22, 2025

Assenagon Asset Management S.A. Boosts Position in Theravance Biopharma, Inc. $TBPH - MarketBeat

Dec 22, 2025

Dec 21, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Dec 21, 2025

Dec 20, 2025

Why Theravance Biopharma Inc. stock could outperform in 2025Portfolio Return Report & Verified Entry Point Detection - Улправда

Dec 20, 2025

How Theravance Biopharma Inc. stock reacts to global recession fears2025 Market WrapUp & AI Driven Stock Movement Reports - Улправда

Dec 20, 2025

How Theravance Biopharma Inc. stock reacts to Fed rate cuts2025 Major Catalysts & Real-Time Volume Triggers - Улправда

Dec 20, 2025

Dec 19, 2025

Will Theravance Biopharma Inc. stock outperform Dow Jones indexMarket Movement Recap & Weekly Stock Breakout Alerts - Улправда

Dec 19, 2025

Is Theravance Biopharma Inc. stock trading near support levelsWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - DonanımHaber

Dec 19, 2025

Will Theravance Biopharma Inc. stock attract ESG investorsMarket Growth Report & Free Community Consensus Stock Picks - DonanımHaber

Dec 19, 2025

Is Theravance Biopharma Inc. (0TB) stock a buy before new product rolloutJuly 2025 Earnings & Short-Term Swing Trade Alerts - DonanımHaber

Dec 19, 2025

Dec 15, 2025